Molecular Design of a Minimal Peptide Nanoparticle

Area of Science:

• Nanomedicine
• Biotechnology
• Materials Science

Background:

• Protein-based nanoparticles offer biocompatibility and biodegradability, addressing toxicity concerns in nanomedicine.
• Self-assembling peptide/protein nanoparticles (SAPNs) have been developed for applications like subunit vaccines.
• Minimizing nanoparticle size is crucial for drug delivery systems to avoid adverse immune responses, such as anaphylaxis.

Purpose of the Study:

• To computationally and biophysically minimize the size of self-assembling peptide/protein nanoparticles (SAPNs) for enhanced drug delivery applications.
• To engineer a minimal SAPN with reduced diameter for safer biomedical use.
• To explore novel avenues for developing safer drug delivery systems and other nanomedical applications.

Main Methods:

• Utilized in silico molecular dynamics simulations to test various charge distributions on pentameric and trimeric coiled-coil domains.
• Employed computational approaches to down-select an optimal SAPN design for minimal size.
• Investigated the selected design in vitro using biophysical methods to confirm size and properties.

Main Results:

• Successfully engineered a minimal self-assembling peptide/protein nanoparticle (SAPN) with a diameter of only 11 nm.
• Identified optimal charge distributions on coiled-coil domains for size reduction.
• Validated the minimal size and potential for drug delivery applications through biophysical characterization.

Conclusions:

• Minimal-sized SAPNs (11 nm) represent a significant advancement for safer drug delivery systems.
• The developed approach offers new possibilities for the development of biocompatible and biodegradable nanomedicines.
• Engineered minimal SAPNs pave the way for safer biomedical applications with reduced immunogenicity.